Literature DB >> 1384094

Digital indocyanine green videoangiography and choroidal neovascularization.

L A Yannuzzi1, J S Slakter, J A Sorenson, D R Guyer, D A Orlock.   

Abstract

This report describes a new system for digital indocyanine green videoangiography (ICGV) that provides enhanced imaging of the choroidal circulation. This newly assembled system was used to study a consecutive series of 129 patients with exudative age-related macular degeneration (AMD), and ill-defined or occult choroidal neovascularization (CNV). Overall, 39% of the patients in this study with occult CNV could be reclassified as having well-delineated or so-called classic CNV by virtue of the additional findings provided by ICGV. In this series, ICGV was particularly useful in identifying occult CNV in eyes with a large, serous pigment epithelial detachment (PED) and in eyes with recurrent CNV after previous laser photocoagulation treatment. Some of these patients were selected for laser photocoagulation of the abnormal choroidal vessels in order to evaluate the feasibility of this form of treatment on the basis of combined clinical, fluorescein angiographic, and ICGV findings. The results of this study suggest that ICGV is an important adjunct in the evaluation, classification, and laser treatment of patients with occult CNV secondary to AMD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384094

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  65 in total

1.  OCT imaging of choroidal neovascularisation and its role in the determination of patients' eligibility for surgery.

Authors:  A Giovannini; G P Amato; C Mariotti; B Scassellati-Sforzolini
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

2.  Occult CNV imaging with scanning laser ophthalmoscope.

Authors:  C Argento; O L Lopez; M M Cartier
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

3.  Radiotherapy for isolated occult subfoveal neovascularisation in age related macular degeneration: a pilot study.

Authors:  G Donati; D Soubrane; M Quaranta; G Coscas; G Soubrane
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

4.  Indocyanine green localisation in surgically excised choroidal neovascular membrane in age related macular degeneration.

Authors:  A A Chang; M Zhu; F A Billson; N L Kumar; P E Beaumont
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

5.  Anatomic response of occult choroidal neovascularization to intravitreal ranibizumab: a study by indocyanine green angiography.

Authors:  Giuseppe Querques; Thi Ha Chau Tran; Raimondo Forte; Lea Querques; Francesco Bandello; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-10-02       Impact factor: 3.117

Review 6.  Choroidal neovascularisation in pathological myopia: an update in management.

Authors:  W-M Chan; M Ohji; T Y Y Lai; D T L Liu; Y Tano; D S C Lam
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

7.  Indocyanine green angiography and fluorescein angiography of malignant choroidal melanomas following proton beam irradiation.

Authors:  Lothar Krause; Nikolaos E Bechrakis; Stefan Heinrich; Klaus-Martin Kreusel; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-17       Impact factor: 3.117

8.  The prevalence of retinal angiomatous proliferation in age-related macular degeneration with occult choroidal neovascularization.

Authors:  Amedeo L Massacesi; Laura Sacchi; Fulvio Bergamini; Ferdinando Bottoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-25       Impact factor: 3.117

9.  Grid laser treatment of occult choroidal neovascularization in age related macular degeneration.

Authors:  F Cardillo Piccolino; D Ghiglione; P Allegri
Journal:  Int Ophthalmol       Date:  1993-04       Impact factor: 2.031

10.  Patterns of indocyanine green videoangiography of choroidal tumours.

Authors:  C L Shields; J A Shields; P De Potter
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.